Precision BioSciences Inc (DTIL)
6.50
-0.68
(-9.47%)
USD |
NASDAQ |
Nov 21, 16:00
6.73
+0.23
(+3.54%)
Pre-Market: 08:29
Precision BioSciences Profit Margin (Quarterly): -2.85K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.85K% |
| June 30, 2024 | 65.63% |
| March 31, 2024 | 48.84% |
| December 31, 2023 | -231.4% |
| September 30, 2023 | -61.58% |
| June 30, 2023 | -60.09% |
| March 31, 2023 | -285.4% |
| December 31, 2022 | -268.8% |
| September 30, 2022 | -325.2% |
| June 30, 2022 | -812.4% |
| March 31, 2022 | -849.2% |
| December 31, 2021 | -351.6% |
| September 30, 2021 | -46.93% |
| June 30, 2021 | 31.47% |
| Date | Value |
|---|---|
| March 31, 2021 | -114.3% |
| December 31, 2020 | -265.1% |
| September 30, 2020 | -353.3% |
| June 30, 2020 | -3.03K% |
| March 31, 2020 | -383.5% |
| December 31, 2019 | -320.7% |
| September 30, 2019 | -426.4% |
| June 30, 2019 | -360.7% |
| March 31, 2019 | -581.9% |
| December 31, 2018 | -312.6% |
| September 30, 2018 | -383.9% |
| June 30, 2018 | -631.1% |
| March 31, 2018 | -589.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.03K%
Minimum
Jun 2020
65.63%
Maximum
Jun 2024
-523.4%
Average
-277.1%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Assembly Biosciences Inc | -140.4% |
| Protagonist Therapeutics Inc | -710.4% |
| Alector Inc | -275.2% |
| Entrada Therapeutics Inc | -71.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.19% |
| Return on Assets | 5.21% |
| Return on Invested Capital | 12.80% |
| Operating Margin (Quarterly) | -3.69K% |
| Return on Net Operating Assets | 27.67% |